Thursday May 24 | CBS News
Teva cuts 2012 profit and sales forecasts
NEW YORK — Teva Pharmaceutical Industries Ltd., the world's largest maker of generic drugs, said Thursday it is cutting its annual profit and sales forecasts.
Mepha Pharma AG - Strategic SWOT Analysis Review - New Study Released
The product portfolio of the company includes minerals, anti-infective drugs, anti-malarial drugs, vitamins and antibiotics.
Teva Pharma 1Q Profit Climbs 13 Percent
Teva Pharmaceutical Industries Ltd.'s first quarter earnings climbed 13 percent as sales of branded drugs added with the acquisition of Cephalon Inc.
Teva-Mylan deal to delay generic Nuvigil
Nuvigil is a treatment for excessive sleepiness associated with sleep apnea, narcolepsy, and shift-work sleep disorder.
Cephalon opens bid for Aussie bio-technology firm Arana
Pennsylvania-based Cephalon Inc on Friday said that its wholly-owned subsidiary, Cephalon International Holdings Inc, plans to make a takeover offer for Arana Therapeutics Limited of Australia, a biopharmaceutical company focused on developing next generation antibody based drugs.